The UK life sciences and technology sectors recently saw significant advancements. The University of Warwick announced a £700 million investment to expand STEM and social science facilities, marking the largest upgrade in its history. The initiative aims to foster innovation through new labs and educational spaces, enhancing research and learning opportunities for students.
To tackle a skills shortage in the medicines manufacturing industry, the government launched a £4.5 million Resilience programme, bridging academia and industry to cultivate talent. At the same time, biotech firm Shift Bioscience secured £12.5 million to advance its AI-powered cell rejuvenation research, which could accelerate the development of anti-ageing therapeutics.
In gene therapy, a £1.4 million grant was awarded to develop an advanced production process for adeno-associated virus (AAV) vectors, potentially reducing manufacturing costs and enhancing therapy accessibility. Additionally, Keysight Technologies and the National Physical Laboratory made a breakthrough in cryogenic radio frequency measurements, which could significantly improve quantum computing and related technologies.
Read more about these key developments here.
